Xencor to Present at Upcoming Investor Conferences

Rhea-AI Summary

Xencor, Inc. (NASDAQ:XNCR), a biopharmaceutical company specializing in engineered monoclonal antibodies and cytokines, has announced its participation in two investor conferences. The Credit Suisse 30th Annual Healthcare Conference will feature a presentation on November 9 at 2:40 p.m. ET. Additionally, the Jefferies London Healthcare Conference will have an on-demand presentation available starting November 18 at 8:00 a.m. GMT. Webcasts will be accessible on the company's website, with replays archived for at least 30 days.

MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate in the following upcoming investor conferences:

• Credit Suisse 30th Annual Healthcare Conference
  Presentation: Tuesday, November 9, 2:40 p.m. ET / 11:40 a.m. PT
  
  
• Jefferies London Healthcare Conference
  Presentation on-demand availability: Thursday, November 18, 8:00 a.m. GMT / 12:00 a.m. PT

Webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays will be archived on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 22 candidates engineered with Xencor's XmAb^® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211102006059/en/

Charles Liles

cliles@xencor.com

Media Contact

Jason I. Spark

Canale Communications

619-849-6005

jason@canalecomm.com

Source: Xencor, Inc.

FAQ

When will Xencor present at the Credit Suisse Healthcare Conference?

Xencor will present at the Credit Suisse 30th Annual Healthcare Conference on November 9 at 2:40 p.m. ET.

What is the date for the Jefferies London Healthcare Conference presentation by Xencor?

The Jefferies London Healthcare Conference presentation by Xencor will be available on-demand starting November 18 at 8:00 a.m. GMT.

Where can I find the webcasts of Xencor's presentations?

Webcasts of Xencor's presentations will be available in the 'Events & Presentations' section of their website.

How long will the replays of Xencor's presentations be available?

Replays of Xencor's presentations will be archived on their website for at least 30 days.

What is Xencor's focus as a biopharmaceutical company?

Xencor focuses on developing engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases.